Technical Analysis for VCNX - Vaccinex, Inc.

Grade Last Price % Change Price Change
grade F 3.64 -1.62% -0.06
VCNX closed down 1.62 percent on Friday, June 5, 2020, on approximately normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical VCNX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish -1.62%
Pocket Pivot Bullish Swing Setup -1.62%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Vaccinex Inc. is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics. The Company is focused on providing treatments for serious diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It provides SEMA4D antibody platform, which is focused on developing its lead product candidate VX15/2503 (VX15) for the treatment of non-small cell lung cancer, NSCLC, osteosarcoma, melanoma and Huntington’s disease. It also provides ActiveMAb antibody discovery platform, a human antibody discovery platform used for expressing large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of vaccinia, a mammalian virus. Its product candidate VX5 is in preclinical development for the treatment of multiple sclerosis and potentially for other autoimmune disorders.
Biotechnology Health Cancer Biology Immunology Antibodies Immune System Monoclonal Antibodies Antibody Multiple Sclerosis Non Small Cell Lung Cancer Serious Diseases Melanoma Autoimmune Disorders Neurodegenerative Diseases Treatment Of Non Small Cell Lung Cancer Osteosarcoma Tolerx Treatment Of Multiple Sclerosis Nsclc Seth Lederman

Is VCNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 12.23
52 Week Low 3.3769
Average Volume 51,201
200-Day Moving Average 5.13
50-Day Moving Average 3.82
20-Day Moving Average 3.79
10-Day Moving Average 3.76
Average True Range 0.26
ADX 11.68
+DI 14.70
-DI 15.88
Chandelier Exit (Long, 3 ATRs ) 3.31
Chandelier Exit (Short, 3 ATRs ) 4.32
Upper Bollinger Band 3.97
Lower Bollinger Band 3.61
Percent B (%b) 0.08
BandWidth 9.41
MACD Line -0.05
MACD Signal Line -0.04
MACD Histogram -0.0073
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.06
Resistance 3 (R3) 4.09 3.98 3.99
Resistance 2 (R2) 3.98 3.87 3.96 3.97
Resistance 1 (R1) 3.81 3.80 3.75 3.78 3.94
Pivot Point 3.70 3.70 3.67 3.68 3.70
Support 1 (S1) 3.53 3.59 3.47 3.50 3.34
Support 2 (S2) 3.42 3.52 3.40 3.31
Support 3 (S3) 3.25 3.42 3.29
Support 4 (S4) 3.22